Cargando…
Multidimensional Impact of Mediterranean Diet on IBD Patients
BACKGROUND & AIMS: Malnutrition with the accumulation of fat tissue and nonalcoholic fatty liver disease (NAFLD) are conditions associated with inflammatory bowel disease (IBD). Visceral fat and NAFLD-related liver dysfunction can both worsen intestinal inflammation. Because the Mediterranean di...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737160/ https://www.ncbi.nlm.nih.gov/pubmed/32440680 http://dx.doi.org/10.1093/ibd/izaa097 |
_version_ | 1783622896079339520 |
---|---|
author | Chicco, Fabio Magrì, Salvatore Cingolani, Arianna Paduano, Danilo Pesenti, Mario Zara, Federica Tumbarello, Francesca Urru, Emanuela Melis, Alessandro Casula, Laura Fantini, Massimo Claudio Usai, Paolo |
author_facet | Chicco, Fabio Magrì, Salvatore Cingolani, Arianna Paduano, Danilo Pesenti, Mario Zara, Federica Tumbarello, Francesca Urru, Emanuela Melis, Alessandro Casula, Laura Fantini, Massimo Claudio Usai, Paolo |
author_sort | Chicco, Fabio |
collection | PubMed |
description | BACKGROUND & AIMS: Malnutrition with the accumulation of fat tissue and nonalcoholic fatty liver disease (NAFLD) are conditions associated with inflammatory bowel disease (IBD). Visceral fat and NAFLD-related liver dysfunction can both worsen intestinal inflammation. Because the Mediterranean diet (Md) has been shown to ameliorate both obesity and NAFLD, the aim of this study was to analyze the impact of Md on the nutritional state, liver steatosis, clinical disease activity, and quality of life (QoL) in IBD patients. METHODS: Patients with IBD, both Crohn’s disease (CD) and ulcerative colitis (UC), followed Md for 6 months. Their body mass index (BMI), body tissue composition, liver steatosis and function, serum lipid profile, clinical disease activity, and inflammatory biomarkers (C-reactive protein and fecal calprotectin) were collected at baseline (T0) and compared with those obtained after 6 months (T180) to evaluate the impact of Md. RESULTS: One hundred forty-two IBD patients, 84 UC and 58 CD, followed Md for 6 months. At T180, diet-adherent CD and UC improved BMI (UC −0.42, P = 0.002; CD −0.48, P = 0.032) and waist circumference (UC −1.25 cm, P = 0.037; CD −1.37 cm, P = 0.041). Additionally, the number of patients affected by liver steatosis of any grade was significantly reduced in both groups (UC T0 31 of 84 [36.9%] vs T180 18 of 84 [21.4%], P = 0.0016; CD T0 27 of 58 [46.6%] vs T180 18 of 58 [31.0%], P < 0.001) after dietary intervention. Finally, after 6 months of the diet, fewer UC and CD patients with stable therapy had active disease (UC T0 14 of 59 [23.7%] vs T180 4 of 59 [6.8%], P = 0.004; CD T0 9 of 51 [17.6%] vs T180 2 of 51 [3.0%], P = 0.011) and elevated inflammatory biomarkers. Mediterranean diet improved QoL in both UC and CD, but neither serum lipid profile nor liver function were modified by the diet. CONCLUSIONS: A significant reduction of malnutrition-related parameters and liver steatosis was observed in both CD and UC patients after short-term dietary intervention based on the adoption of Md, and this was associated with a spontaneous improvement of disease activity and inflammatory markers. |
format | Online Article Text |
id | pubmed-7737160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77371602020-12-17 Multidimensional Impact of Mediterranean Diet on IBD Patients Chicco, Fabio Magrì, Salvatore Cingolani, Arianna Paduano, Danilo Pesenti, Mario Zara, Federica Tumbarello, Francesca Urru, Emanuela Melis, Alessandro Casula, Laura Fantini, Massimo Claudio Usai, Paolo Inflamm Bowel Dis Leading Off BACKGROUND & AIMS: Malnutrition with the accumulation of fat tissue and nonalcoholic fatty liver disease (NAFLD) are conditions associated with inflammatory bowel disease (IBD). Visceral fat and NAFLD-related liver dysfunction can both worsen intestinal inflammation. Because the Mediterranean diet (Md) has been shown to ameliorate both obesity and NAFLD, the aim of this study was to analyze the impact of Md on the nutritional state, liver steatosis, clinical disease activity, and quality of life (QoL) in IBD patients. METHODS: Patients with IBD, both Crohn’s disease (CD) and ulcerative colitis (UC), followed Md for 6 months. Their body mass index (BMI), body tissue composition, liver steatosis and function, serum lipid profile, clinical disease activity, and inflammatory biomarkers (C-reactive protein and fecal calprotectin) were collected at baseline (T0) and compared with those obtained after 6 months (T180) to evaluate the impact of Md. RESULTS: One hundred forty-two IBD patients, 84 UC and 58 CD, followed Md for 6 months. At T180, diet-adherent CD and UC improved BMI (UC −0.42, P = 0.002; CD −0.48, P = 0.032) and waist circumference (UC −1.25 cm, P = 0.037; CD −1.37 cm, P = 0.041). Additionally, the number of patients affected by liver steatosis of any grade was significantly reduced in both groups (UC T0 31 of 84 [36.9%] vs T180 18 of 84 [21.4%], P = 0.0016; CD T0 27 of 58 [46.6%] vs T180 18 of 58 [31.0%], P < 0.001) after dietary intervention. Finally, after 6 months of the diet, fewer UC and CD patients with stable therapy had active disease (UC T0 14 of 59 [23.7%] vs T180 4 of 59 [6.8%], P = 0.004; CD T0 9 of 51 [17.6%] vs T180 2 of 51 [3.0%], P = 0.011) and elevated inflammatory biomarkers. Mediterranean diet improved QoL in both UC and CD, but neither serum lipid profile nor liver function were modified by the diet. CONCLUSIONS: A significant reduction of malnutrition-related parameters and liver steatosis was observed in both CD and UC patients after short-term dietary intervention based on the adoption of Md, and this was associated with a spontaneous improvement of disease activity and inflammatory markers. Oxford University Press 2020-05-22 /pmc/articles/PMC7737160/ /pubmed/32440680 http://dx.doi.org/10.1093/ibd/izaa097 Text en © 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Leading Off Chicco, Fabio Magrì, Salvatore Cingolani, Arianna Paduano, Danilo Pesenti, Mario Zara, Federica Tumbarello, Francesca Urru, Emanuela Melis, Alessandro Casula, Laura Fantini, Massimo Claudio Usai, Paolo Multidimensional Impact of Mediterranean Diet on IBD Patients |
title | Multidimensional Impact of Mediterranean Diet on IBD Patients |
title_full | Multidimensional Impact of Mediterranean Diet on IBD Patients |
title_fullStr | Multidimensional Impact of Mediterranean Diet on IBD Patients |
title_full_unstemmed | Multidimensional Impact of Mediterranean Diet on IBD Patients |
title_short | Multidimensional Impact of Mediterranean Diet on IBD Patients |
title_sort | multidimensional impact of mediterranean diet on ibd patients |
topic | Leading Off |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737160/ https://www.ncbi.nlm.nih.gov/pubmed/32440680 http://dx.doi.org/10.1093/ibd/izaa097 |
work_keys_str_mv | AT chiccofabio multidimensionalimpactofmediterraneandietonibdpatients AT magrisalvatore multidimensionalimpactofmediterraneandietonibdpatients AT cingolaniarianna multidimensionalimpactofmediterraneandietonibdpatients AT paduanodanilo multidimensionalimpactofmediterraneandietonibdpatients AT pesentimario multidimensionalimpactofmediterraneandietonibdpatients AT zarafederica multidimensionalimpactofmediterraneandietonibdpatients AT tumbarellofrancesca multidimensionalimpactofmediterraneandietonibdpatients AT urruemanuela multidimensionalimpactofmediterraneandietonibdpatients AT melisalessandro multidimensionalimpactofmediterraneandietonibdpatients AT casulalaura multidimensionalimpactofmediterraneandietonibdpatients AT fantinimassimoclaudio multidimensionalimpactofmediterraneandietonibdpatients AT usaipaolo multidimensionalimpactofmediterraneandietonibdpatients |